Structures by: Bal C.
Total: 7
Carbocyclic nucleoside
C14H17ClN4O3
RSC Medicinal Chemistry (2020)
a=8.6168(4)Å b=6.7974(3)Å c=13.2395(5)Å
α=90° β=99.344(4)° γ=90°
Pyranone carboxamide
C20H24N2O4
RSC Adv. (2014) 4, 33 17354
a=8.0084(5)Å b=11.0499(7)Å c=11.0645(7)Å
α=70.326(5)° β=80.844(5)° γ=71.336(6)°
1,3-bis(8-chlorotheophyllin-7-yl)propane
C17H18Cl2N8O4
Acta Crystallographica Section E (2001) 57, 12 o1163-o1165
a=19.9290(10)Å b=4.3417(2)Å c=22.788(2)Å
α=90.00° β=91.400(10)° γ=90.00°
Pyrazolo[3,4-d]pyrimidine
C18H17N5O2S2
Acta Crystallographica Section C (2003) 59, 8 o409-o412
a=10.4710(10)Å b=13.1323(11)Å c=14.0516(12)Å
α=90.00° β=102.190(10)° γ=90.00°
Parazolo[3,4-d]pyrimidine
C21H22N6O2S
Acta Crystallographica Section C (2003) 59, 8 o409-o412
a=7.5993(6)Å b=9.3968(7)Å c=15.376(2)Å
α=80.684(8)° β=82.480(10)° γ=72.685(6)°
Pyrazolo[3,4-d]pyrimidine
C17H20N4OS2
Acta Crystallographica Section C (2003) 59, 9 o494-o495
a=17.9660(10)Å b=10.0890(10)Å c=10.0550(10)Å
α=90.00° β=104.970(10)° γ=90.00°
C19.5H16.5Cl1.5N2O4
C19.5H16.5Cl1.5N2O4
ACS medicinal chemistry letters (2014) 5, 3 259-263
a=10.5477(9)Å b=14.464(2)Å c=14.486(2)Å
α=62.635(15)° β=70.780(10)° γ=86.674(9)°